Controlling Brain Cells With Light: Ethical Considerations for Optogenetic Clinical Trials

By Gilbert Frederic   Harris Alexander R.   Kapsa Robert M. I.  

AJOB Neuroscience, Vol. 5, Iss. 3, 2014-07 ,pp. : 3-11

Taylor & Francis Ltd

Access to resources Recommend Favorite

Clazosentan, a novel endothelin A antagonist, improves cerebral blood flow and behavior after traumatic brain injury

By Kreipke Christian W   Rafols José A   Reynolds Christian A   Schafer Steven   Marinica Alex   Bedford Christopher   Fronczak Michael   Kuhn Donald   Armstead William M  

Neurological Research, Vol. 33, Iss. 2, 2011-03 ,pp. : 208-213

Maney Publishing

Access to resources Recommend Favorite

Trials and tribulations of clinical research: promoting Parkinson’s patient participation

By Stamford Jon   Willocks Peggy  

Neurodegenerative Disease Management, Vol. 3, Iss. 5, 2013-10 ,pp. : 393-395

Future Medicine

Access to resources Recommend Favorite

Gene Therapy Approaches to Parkinson's Disease: Preclinical to Clinical Trials, or What Steps to Take to Get There from Here?

By Redmond D.E.  

Experimental Neurology, Vol. 144, Iss. 1, 1997-03 ,pp. : 160-167

Elsevier

Access to resources Recommend Favorite

Current Management of Delayed Cerebral Ischemia: Update from Results of Recent Clinical Trials

By Brathwaite Shakira   Macdonald R.  

Translational Stroke Research, Vol. 5, Iss. 2, 2014-04 ,pp. : 207-226

Springer Publishing Company

Access to resources Recommend Favorite